Atlas Trials

Real-World Use of Novel Treatments in Patients With Spinal Muscular Atrophy (SMA): A Multi-Site Retrospective Chart Review of Pediatric SMA Patients Outside of the United States

Clinical trial NCT06178393 · COMPLETED

Trial details

NCT number
NCT06178393
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Study type
OBSERVATIONAL
Spinal Muscular Atrophy
Start date
2022-05-05
Primary completion
2022-12-30
Enrollment
162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.